Clinical Trials List
2018-12-07 - 2024-12-31
Phase III
Terminated6
ICD-10C34
Malignant neoplasm of bronchus and lung
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- James Chih-Hsin Yang Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- 徐偉勛 醫學研究部
- 蔡子修 Division of General Internal Medicine
- 林育麟 Division of Hematology & Oncology
- 廖唯昱 Division of General Internal Medicine
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- JIN-YUAN SHIH Division of General Internal Medicine
- 陳冠宇 Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- 許嘉林 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 蕭慈慧 Division of Thoracic Medicine
- Chi-Lu Chiang Division of Thoracic Medicine
- Hsu-ching Huang 無
- Chao-Hua Chiu Division of Hematology & Oncology
- Heng-Sheng Chao 未分科
- 趙恒勝 Division of Thoracic Medicine
- 楊朝能 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
3 Completed
Audit
None
Co-Principal Investigator
- 王逸熙 Division of Thoracic Medicine
- 張晃智 Division of Thoracic Medicine
- Shau-Hsuan Li Division of Hematology & Oncology
- 鍾聿修 Division of Thoracic Medicine
- 黃國棟 Division of Thoracic Medicine
- 林理涵 Division of Radiology
- 趙東瀛 Division of Thoracic Medicine
- Chia-Cheng Tseng Division of Thoracic Medicine
- 李易濰 Division of Radiology
- 林孟志 Division of Thoracic Medicine
- 賴建豪 Division of Thoracic Medicine
- 陳彥豪 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Wen-Pin Su Division of General Internal Medicine
- Shang-Yin Wu Division of General Internal Medicine
- Jui-Hung Tsai Division of General Internal Medicine
- Yu-Min Yeh Division of General Internal Medicine
- Po-Lan Su Division of General Internal Medicine
- Wu-Chou Su Division of General Internal Medicine
- Wei-Pang Chung Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
Taiwan National PI
Co-Principal Investigator
- Wen-Cheng Chang Division of Hematology & Oncology
- Chih-Liang Wang Division of Hematology & Oncology
- 黃振洋 Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- Ping-Chih Hsu Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- 柯皓文 Division of Hematology & Oncology
- Chih-Hsi Kuo Division of Hematology & Oncology
- 枋岳甫 Division of Infectious Disease
- Chih-Hung Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
4 Completed
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15-30 participants
-
Global
627 participants
